OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
QUAL3$1.9060

Qualicorp Consultoria e Corretora de Seguros SA

Multiline Insurance & BrokersVerified

Qualicorp's capital structure is characterized by a debt-to-equity ratio of 1.37, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.91, suggesting limited short-term liquidity cushion. The price-to-book ratio of 0.42 implies that the company's market value is significantly below its book value, potentially signaling undervaluation or asset impairment concerns. Profitability metrics reveal a return on equity (ROE) of 0.83% and a return on assets (ROA) of 0.27%, both of which are below the industry norms for multiline insurance and brokers. The company's operating income margin is 19.63% (279,975,000 / 1,426,845,000), which is relatively low for a company in the insurance sector. The net income margin is 0.75% (10,665,000 / 1,426,845,000), further underscoring the company's weak profitability. Qualicorp's revenue is primarily concentrated in Brazil, with no disclosed international operations. The company's Affinity and Corporate divisions are its primary revenue sources, but the financial data does not provide a breakdown of revenue by segment or geography. The lack of diversification could expose the company to regional economic and regulatory risks. The company's growth trajectory is modest, with no specific numeric deltas provided for the current or next fiscal year. The operating cash flow of 286,480,000 and free cash flow of 116,204,000 indicate some capacity for reinvestment or debt reduction, but the capital expenditure of -182,187,000 suggests a reduction in capital spending. The absence of a clear growth strategy is evident in the weak profitability and low ROE. Risk factors include a medium liquidity risk, as the company's cash and equivalents (222,662,000) are insufficient to cover its long-term debt (1,762,322,000). The dilution risk is assessed as low, with no significant changes in shares outstanding between basic and diluted shares. The risk assessment highlights a key flag of negative net cash after subtracting total debt, indicating potential liquidity constraints. Recent events include analyst estimates with a mean price target of 2.82 BRL and a median price target of 2.75 BRL. The mean recommendation is 3.00, indicating a neutral stance, with four hold recommendations and one strong buy. No recent filings or transcripts are provided to detail specific events or strategic initiatives.

30-day price · QUAL3-0.04 (-2.1%)
Low$1.71High$2.42Close$1.88As of12 May, 00:00 UTC
Profile
CompanyQualicorp Consultoria e Corretora de Seguros SA
TickerQUAL3.SA
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryMultiline Insurance & Brokers
AI analysis

Business. Qualicorp Consultoria e Corretora de Seguros SA operates in the healthcare insurance sector, primarily administering and managing healthcare plans, including group health and dental insurance, through its Affinity and Corporate divisions.

Classification. Qualicorp is classified under the Financials economic sector, Insurance business sector, and Multiline Insurance & Brokers industry, with a confidence level of 0.92.

Qualicorp's capital structure is characterized by a debt-to-equity ratio of 1.37, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.91, suggesting limited short-term liquidity cushion. The price-to-book ratio of 0.42 implies that the company's market value is significantly below its book value, potentially signaling undervaluation or asset impairment concerns. Profitability metrics reveal a return on equity (ROE) of 0.83% and a return on assets (ROA) of 0.27%, both of which are below the industry norms for multiline insurance and brokers. The company's operating income margin is 19.63% (279,975,000 / 1,426,845,000), which is relatively low for a company in the insurance sector. The net income margin is 0.75% (10,665,000 / 1,426,845,000), further underscoring the company's weak profitability. Qualicorp's revenue is primarily concentrated in Brazil, with no disclosed international operations. The company's Affinity and Corporate divisions are its primary revenue sources, but the financial data does not provide a breakdown of revenue by segment or geography. The lack of diversification could expose the company to regional economic and regulatory risks. The company's growth trajectory is modest, with no specific numeric deltas provided for the current or next fiscal year. The operating cash flow of 286,480,000 and free cash flow of 116,204,000 indicate some capacity for reinvestment or debt reduction, but the capital expenditure of -182,187,000 suggests a reduction in capital spending. The absence of a clear growth strategy is evident in the weak profitability and low ROE. Risk factors include a medium liquidity risk, as the company's cash and equivalents (222,662,000) are insufficient to cover its long-term debt (1,762,322,000). The dilution risk is assessed as low, with no significant changes in shares outstanding between basic and diluted shares. The risk assessment highlights a key flag of negative net cash after subtracting total debt, indicating potential liquidity constraints. Recent events include analyst estimates with a mean price target of 2.82 BRL and a median price target of 2.75 BRL. The mean recommendation is 3.00, indicating a neutral stance, with four hold recommendations and one strong buy. No recent filings or transcripts are provided to detail specific events or strategic initiatives.
Key takeaways
  • Qualicorp's debt-to-equity ratio of 1.37 and current ratio of 0.91 indicate a moderate reliance on debt and limited short-term liquidity.
  • The company's ROE of 0.83% and ROA of 0.27% are below industry norms, reflecting weak profitability.
  • Revenue concentration in Brazil and lack of international diversification expose the company to regional risks.
  • Analysts have a neutral stance on the stock, with a mean price target of 2.82 BRL and a median price target of 2.75 BRL.
  • The company's liquidity risk is medium, with cash and equivalents insufficient to cover long-term debt.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyBRL
Revenue$1.43B
Gross profit$1.24B
Operating income$280.0M
Net income$10.7M
R&D
SG&A
D&A
SBC
Operating cash flow$286.5M
CapEx-$182.2M
Free cash flow$116.2M
Total assets$3.94B
Total liabilities$2.65B
Total equity$1.29B
Cash & equivalents$222.7M
Long-term debt$1.76B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$1.90
Market cap$537.9M
Enterprise value$2.08B
P/E50.4
Reported non-GAAP P/E
EV/Revenue1.5
EV/Op income7.4
EV/OCF7.2
P/B0.4
P/Tangible book0.4
Tangible book$1.29B
Net cash-$1.54B
Current ratio0.9
Debt/Equity1.4
ROA0.3%
ROE0.8%
Cash conversion26.9%
CapEx/Revenue-12.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Asset Management · cohort 1 companies
MetricQUAL3Activity
Op margin19.6%12.9% medp25 6.7% · p75 19.1%top quartile
Net margin0.7%6.9% medp25 2.4% · p75 13.4%bottom quartile
Gross margin87.1%46.2% medp25 28.1% · p75 79.0%top quartile
CapEx / revenue-12.8%1.5% medp25 1.5% · p75 1.5%bottom quartile
Debt / equity137.0%104.3% medp25 78.1% · p75 130.5%top quartile
Observations
IR observations
Mean price target2.82 BRL
Median price target2.75 BRL
High price target4.00 BRL
Low price target2.00 BRL
Mean recommendation3.00 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count0.00
Hold count4.00
Sell count2.00
Strong-sell count0.00
Mean EPS estimate0.44 BRL
Last actual EPS0.04 BRL
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 12:06 UTC#d6d19ace
Market quoteclose BRL 1.90 · shares 0.28B diluted
no public URL
2026-05-10 12:06 UTC#8e7db464
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 12:08 UTCJob: 69f4ceaa